Cash & equivalents increased 25.8%
Cash & equivalents changed +25.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +25.8% from the comparable as-filed period.
Net income changed -26.5% from the comparable as-filed period.
Operating income changed -21.7% from the comparable as-filed period.
Operating margin changed -464 basis points from the comparable as-filed period.
Gross profit changed -13.0% from the comparable as-filed period.
Inventory changed +19.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross margin changed -136 basis points from the comparable as-filed period.
Revenue changed -11.4% from the comparable as-filed period.
Selling, general & administrative changed -9.2% from the comparable as-filed period.
Research & development changed -3.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.